Dual RAAS blockage in primary glomerular diseases
Not Applicable
- Registration Number
- CTRI/2023/05/052593
- Lead Sponsor
- Department of Nephrology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with primary glomerular diseases â?? MN, FSGS, IgAn, iMPGN, MCD
2. Patients with who have received single RAAS blocking agent (LOSARTAN 100 mg) for atleast 4 weeks and having proteinuria more than 500 mg/day
3. Age >12 years
4. Either sex
Exclusion Criteria
1. Secondary glomerulonephritis.
2. Prior history of angioedema
3. Bilateral renal artery stenosis
4. Pregnancy
5. Serum Potassium more than 5.1 mmol/L
6. eGFR < 30 ml/min
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method